HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The OPT-CHF (Oxypurinol Therapy for Congestive Heart Failure) trial: a question of dose.

AuthorsJacob George, Allan Struthers
JournalJournal of the American College of Cardiology (J Am Coll Cardiol) Vol. 53 Issue 25 Pg. 2405 (Jun 23 2009) ISSN: 1558-3597 [Electronic] United States
PMID19539154 (Publication Type: Comment, Letter)
Chemical References
  • Xanthine Oxidase
  • Oxypurinol
Topics
  • Dose-Response Relationship, Drug
  • Heart Failure (drug therapy)
  • Humans
  • Oxypurinol (administration & dosage)
  • Xanthine Oxidase (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: